The enemy of DXB share price are non other than its own retail investors (particular 12.6C option holders) who seems to be more nervous than anyone else about the March Result. It is matter of another 9 or 10 trading days when they will realise that they would have trusted the DXB management. The top 5 holders hold most of the options, however they are unmoved and here we're, holding few hundred thousands worry too much. Trust your investment, this could be life changing like Nuren, however, DYOR for any buy or sell.
Interim Analyses of Clinical Trials, page-146
Add DXB (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
47.0¢ |
Change
0.025(5.62%) |
Mkt cap ! $261.8M | |||
| Open | High | Low | Value | Volume |
| 45.5¢ | 49.5¢ | 45.0¢ | $2.042M | 4.280M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 98853 | 47.0¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 47.5¢ | 20000 | 1 |
View Market Depth
| Last trade - 16.10pm 14/10/2024 (20 minute delay) ? |
| DXB (ASX) Chart |